Gamaleya’s Covid-19 vaccine Sputnik V approved in Russia
The Sechenov First Moscow State Medical University (Sechenov University) has evaluated the vaccine in early-stage clinical trials
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
12 Aug 20
The Sechenov First Moscow State Medical University (Sechenov University) has evaluated the vaccine in early-stage clinical trials
11 Aug 20
The US regulatory agency has previously granted an Emergency Use Authorisation (EUA) for remdesivir, allowing the treatment of…
10 Aug 20
The FDA approval of Evrysdi is based on data from two clinical studies, dubbed FIREFISH in symptomatic infants,…
07 Aug 20
The EC approval is based on efficacy and safety record of Xolair in severe allergic asthma and chronic…
06 Aug 20
BLENREP combines humanised anti-B cell maturation antigen (BCMA) monoclonal antibody with the cytotoxic agent auristatin F through a…
04 Aug 20
The FDA approval is based on Phase 3 data showing Spravato reduced depressive symptoms, with symptom improvement maintained…
04 Aug 20
The EMA has granted Priority Medicines (PRIME) designation to Rozlytrek for the treatment of NTRK fusion-positive, metastatic solid…
31 Jul 20
The Tecentriq combination helped people live longer without their disease worsening or progression-free survival (PFS) than placebo plus…
31 Jul 20
STELARA was previously approved for moderate to severe plaque psoriasis in adults, which is now expanded to include…
30 Jul 20
The European regulatory approval was based on Phase 3 SOLAR-1 trial, which showed that Piqray plus fulvestrant almost…